January 24, 2025 - 21:18

The University of Minnesota and Essentia Health have announced plans to establish a new nonprofit organization aimed at enhancing academic medicine in Minnesota. This initiative seeks to create a collaborative framework that will foster innovation and improve health care delivery in the region.
Currently, the University of Minnesota operates under a collaborative agreement with Fairview Health Services, which is set to conclude next year. The transition to a partnership with Essentia Health represents a strategic shift in the university's approach to health care collaboration.
The proposed alliance is expected to leverage the strengths of both institutions, focusing on research, education, and patient care. By combining resources and expertise, the partnership aims to advance medical education and improve health outcomes for communities in Minnesota. Stakeholders are optimistic that this new alliance will pave the way for groundbreaking advancements in health care and solidify Minnesota's position as a leader in academic medicine.
November 1, 2025 - 03:51
Tammy Derk Appointed Vice President of Children's Services at Penn State HealthPenn State Health has appointed Tammy Derk as the new administrative vice president of its Children’s services, marking a significant leadership change within the organization. With over 30 years...
October 31, 2025 - 01:14
Honoring the Champions of Public HealthAt the 2025 Awards Gala and Silent Auction, the National Foundation for Infectious Diseases celebrated the remarkable contributions of three distinguished public health champions: Anne E. Goldfeld,...
October 30, 2025 - 08:19
Major Reductions in Federal Mental Health and Addiction Agency Under Trump AdministrationThe Trump administration has significantly diminished the federal agency responsible for mental health and addiction treatment, leading to a reduction of its workforce by over 50%. This drastic cut...
October 29, 2025 - 18:25
Federal Regulators Aim to Lower Costs of Biotech MedicationsFederal regulators are taking significant steps to facilitate the development of more affordable alternatives to essential biotech drugs that millions of Americans rely on for treating serious...